Emmaus Life Sciences Garners $20,000,000 New Funding

  • Feed Type
  • Date
    10/17/2016
  • Company Name
    Emmaus Life Sciences
  • Mailing Address
    21250 Hawthorne Blvd. Torrance, CA 90503 USA
  • Company Description
    Emmaus Life Sciences, Inc. is conducting a clinical trial for L-glutamine for sickle cell disease.
  • Website
    http://www.emmausmedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy